OpenURL Connection Search

Select item for more details and to access through your institution.

Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.
Published in:
Liver International, 2013, v. 33, n. 5, p. 771, doi. 10.1111/liv.12124
By:
- Galassi, Marzia;
- Iavarone, Massimo;
- Rossi, Sandro;
- Bota, Simona;
- Vavassori, Sara;
- Rosa, Laura;
- Leoni, Simona;
- Venerandi, Laura;
- Marinelli, Sara;
- Sangiovanni, Angelo;
- Veronese, Letizia;
- Fraquelli, Mirella;
- Granito, Alessandro;
- Golfieri, Rita;
- Colombo, Massimo;
- Bolondi, Luigi;
- Piscaglia, Fabio
Publication type:
Article
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging.
Published in:
Digestive Diseases, 2015, v. 33, n. 6, p. 735, doi. 10.1159/000439097
By:
- Piscaglia, Fabio;
- Iavarone, Massimo;
- Galassi, Marzia;
- Vavassori, Sara;
- Renzulli, Matteo;
- Forzenigo, Laura Virginia;
- Granito, alessandro;
- Salvatore, Veronica;
- Sangiovanni, angelo;
- Golfieri, Rita;
- Colombo, Massimo;
- Bolondi, Luigi
Publication type:
Article
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE-1 study.
Published in:
International Journal of Cancer, 2014, v. 135, n. 5, p. 1247, doi. 10.1002/ijc.28772
By:
- Scartozzi, Mario;
- Faloppi, Luca;
- Svegliati Baroni, Gianluca;
- Loretelli, Cristian;
- Piscaglia, Fabio;
- Iavarone, Massimo;
- Toniutto, Pierluigi;
- Fava, Giammarco;
- De Minicis, Samuele;
- Mandolesi, Alessandra;
- Bianconi, Maristella;
- Giampieri, Riccardo;
- Granito, Alessandro;
- Facchetti, Floriana;
- Bitetto, Davide;
- Marinelli, Sara;
- Venerandi, Laura;
- Vavassori, Sara;
- Gemini, Stefano;
- D'Errico, Antonietta
Publication type:
Article

Found: 3

Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.

Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging.

VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE-1 study.